USPTO Retreats from Patent Petition Rule Overhaul Proposal
Published Date: 10/17/2025
Proposed Rule
Summary
The USPTO is pulling back a proposed rule that would have changed how patent challenges are handled by the Patent Trial and Appeal Board. This affects inventors, companies, and lawyers who deal with patent reviews, as the changes around multiple petitions and settlements won’t happen now. No new fees or deadlines are coming from this, but stay tuned for future updates!
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
USPTO Withdraws PTAB Rule Changes
On October 17, 2025, the USPTO withdrew the proposed rule published April 19, 2024 (89 FR 28693) that would have revised rules for inter partes review (IPR) and post-grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB). The proposed changes involving serial petitions, parallel petitions, petitions implicating the same or substantially the same art or arguments, a separate briefing process for discretionary institution arguments, and aligned settlement/termination procedures will not move forward at this time.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16744, Request for Comments on Community Outreach Office Locations in the Southwest States
The USPTO wants your ideas on where to open new community outreach offices in the Southwest states like Arizona and Texas. These offices will help inventors, small businesses, and students get better support with patents. Share your thoughts by September 16, 2026, so the USPTO can pick the best spots and keep innovation booming without extra costs to you!
2026-16315, Administrative Updates to the General Requirements Bulletin for Admission to the Examination for Registration To Practice in Patent Cases Before the United States Patent and Trademark Office
Starting August 11, 2026, the USPTO is upgrading Biomedical Science degrees from Category B to Category A for patent bar eligibility. This means more people with this degree can now take the patent exam and become patent practitioners. No extra fees or delays—just a smoother path for those with the right science background to join the patent world!
2026-14941, Grant of Interim Extension of the Term of U.S. Patent No. 8,461,196; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means they keep exclusive rights to the drug until July 25, 2027, giving them more time to sell it without competition. This extension helps the company protect their investment while the drug gets final approval.
2026-14939, Grant of Interim Extension of the Term of U.S. Patent No. 8,877,798; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means their patent, which was set to expire on July 25, 2026, now lasts until July 25, 2027. This extension helps Otsuka keep exclusive rights to their drug a bit longer while waiting for final FDA approval.
2026-14793, Requirement To Identify All Real Parties in Interest to a Third Party Request for an Ex Parte Reexamination
The USPTO wants anyone asking for a third-party ex parte reexamination to clearly say who’s really behind the request. This helps stop sneaky tricks and keeps the process honest. If you’re involved, get ready to share this info confidentially by August 21, 2026, or risk delays or issues.
2026-14388, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Admission to Practice and Roster of Registered Patent Attorneys and Agents Admitted to Practice Before the United States Patent and Trademark Office
The USPTO is asking for public feedback on its paperwork rules for patent attorneys and agents who want to practice before the office. This helps keep the process smooth and fair without making people fill out too many forms. If you have thoughts, send them in by August 17, 2026—no fees or big changes are happening right now, just a review.
Previous / Next Documents
Previous: 2025-19580, Revision to Rules of Practice Before the Patent Trial and Appeal Board
The USPTO wants to change the rules for how patent challenges happen before the Patent Trial and Appeal Board. These updates affect inventors, companies, and lawyers by making the review process clearer and possibly faster. If you want to share your thoughts, you need to comment by November 17, 2025—so don’t wait!
Next: 2025-19608, Implementation of the Executive Order Entitled “Zero-Based Regulatory Budgeting To Unleash American Energy”
The government is rolling out a new plan called Zero-Based Regulatory Budgeting to help boost American energy by cutting unnecessary rules. This means agencies must carefully review and limit new regulations to keep energy costs down and speed up projects. The changes affect all energy-related agencies and start right away, aiming to save money and unleash more energy production.